naftopidil

Known as: 1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The aim of the present study was to compare the efficacy of the selective α(1D) -adrenoceptor antagonist naftopidil and the… (More)
Is this relevant?
2009
2009
PURPOSE Naftopidil is a specific alpha1D-adrenergic receptor antagonist. We performed the current randomized, controlled study to… (More)
Is this relevant?
2009
2009
BACKGROUND Recently, alpha(1)-adrenoceptors (alpha(1)-ARs) have been reported to play a prominent role in the growth of a variety… (More)
  • table I
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2009
2009
Conformational restriction of naftopidil proved to be compatible with binding at alpha(1) adrenoceptor subtypes and 5-HT receptor… (More)
Is this relevant?
2008
2008
OBJECTIVES The clinical usefulness of naftopidil was evaluated in 122 patients with benign prostatic hyperplasia for urinary… (More)
Is this relevant?
2008
2008
OBJECTIVES In order to compare the clinical efficacy of naftopidil (Naf) and tamsulosin hydrochloride (Tam), which differ in… (More)
Is this relevant?
2006
2006
AIM The aim of this study was to compare the efficacy and safety of alpha1-adrenoceptor (alpha1-AR) antagonist monotherapy with… (More)
Is this relevant?
2002
2002
The effects of intrathecal injection of tamsulosin (an alpha-1A adrenergic receptor antagonist) and naftopidil (an alpha-1D… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The pharmacological profiles of the alpha1-adrenoceptor antagonists naftopidil, tamsulosin and prazosin were studied in an… (More)
Is this relevant?